212 related articles for article (PubMed ID: 21784461)
1. Stimulation of soluble guanylate cyclase improves renal recovery after relief of unilateral ureteral obstruction.
Wang-Rosenke Y; Mika A; Khadzhynov D; Loof T; Neumayer HH; Peters H
J Urol; 2011 Sep; 186(3):1142-9. PubMed ID: 21784461
[TBL] [Abstract][Full Text] [Related]
2. Impact of biological gender and soluble guanylate cyclase stimulation on renal recovery after relief of unilateral ureteral obstruction.
Wang-Rosenke Y; Mika A; Khadzhynov D; Loof T; Neumayer HH; Peters H
J Urol; 2012 Jul; 188(1):316-23. PubMed ID: 22608751
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
5. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
[TBL] [Abstract][Full Text] [Related]
6. Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia.
Liu CM; Fan YC; Lo YC; Wu BN; Yeh JL; Chen IJ
Int J Urol; 2014 Jan; 21(1):87-92. PubMed ID: 23692571
[TBL] [Abstract][Full Text] [Related]
7. The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease.
Reinhart GA; Harrison PC; Lincoln K; Chen H; Sun P; Hill J; Qian HS; McHugh MC; Clifford H; Ng KJ; Wang H; Fowler D; Gueneva-Boucheva K; Brenneman JB; Bosanac T; Wong D; Fryer RM; Sarko C; Boustany-Kari CM; Pullen SS
J Pharmacol Exp Ther; 2023 Mar; 384(3):382-392. PubMed ID: 36507845
[TBL] [Abstract][Full Text] [Related]
8. Soluble guanylate cyclase stimulators in pulmonary hypertension.
Stasch JP; Evgenov OV
Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of soluble guanylate cyclase stimulators and activators: a review of the preclinical evidence.
Stasch JP; Schlossmann J; Hocher B
Curr Opin Pharmacol; 2015 Apr; 21():95-104. PubMed ID: 25645316
[TBL] [Abstract][Full Text] [Related]
10. Recovery following relief of unilateral ureteral obstruction in the neonatal rat.
Chevalier RL; Kim A; Thornhill BA; Wolstenholme JT
Kidney Int; 1999 Mar; 55(3):793-807. PubMed ID: 10027917
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia.
Stancu B; Krämer S; Loof T; Mika A; Amann K; Neumayer HH; Peters H
J Hypertens; 2015 Sep; 33(9):1907-20; discussion 1921. PubMed ID: 26176653
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
[TBL] [Abstract][Full Text] [Related]
13. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats.
Ito K; Chen J; Seshan SV; Khodadadian JJ; Gallagher R; El Chaar M; Vaughan ED; Poppas DP; Felsen D
Kidney Int; 2005 Aug; 68(2):515-28. PubMed ID: 16014028
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction.
Kellner D; Chen J; Richardson I; Seshan SV; El Chaar M; Vaughan ED; Poppas D; Felsen D
J Urol; 2006 Aug; 176(2):806-12. PubMed ID: 16813952
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Characterization of IW-1973, a Novel Soluble Guanylate Cyclase Stimulator with Extensive Tissue Distribution, Antihypertensive, Anti-Inflammatory, and Antifibrotic Effects in Preclinical Models of Disease.
Tobin JV; Zimmer DP; Shea C; Germano P; Bernier SG; Liu G; Long K; Miyashiro J; Ranganath S; Jacobson S; Tang K; Im GJ; Sheppeck J; Moore JD; Sykes K; Wakefield J; Sarno R; Banijamali AR; Profy AT; Milne GT; Currie MG; Masferrer JL
J Pharmacol Exp Ther; 2018 Jun; 365(3):664-675. PubMed ID: 29643251
[TBL] [Abstract][Full Text] [Related]
17. Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats.
Ito K; Chen J; El Chaar M; Stern JM; Seshan SV; Khodadadian JJ; Richardson I; Hyman MJ; Vaughan ED; Poppas DP; Felsen D
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1283-93. PubMed ID: 15328069
[TBL] [Abstract][Full Text] [Related]
18. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
Loganathan S; Korkmaz-Icöz S; Radovits T; Li S; Mikles B; Barnucz E; Hirschberg K; Karck M; Szabó G
J Heart Lung Transplant; 2015 Oct; 34(10):1346-53. PubMed ID: 26210750
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
[TBL] [Abstract][Full Text] [Related]
20. Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction.
Miyajima A; Asano T; Asano T; Yoshimura I; Seta K; Hayakawa M
J Urol; 2001 May; 165(5):1714-8. PubMed ID: 11342962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
